GE11 Modified PLGA/TPGS Nanoparticles Targeting Delivery of Salinomycin to Breast Cancer Cells

Salinomycin (Sal) is a potent inhibitor with effective anti-breast cancer properties in clinical therapy. The occurrence of various side effect of Sal greatly limits its application. The epidermal growth factor receptor (EGFR) family is a family of receptors highly expressed in most breast cancer ce...

Full description

Bibliographic Details
Main Authors: Kaichun Li MD, Liying Pang MS, Xiaorong Pan MS, Shaonan Fan MS, Xinxin Wang MS, Qiaoyun Wang MS, Ping Dai MS, Wei Gao MD, Jie Gao PhD
Format: Article
Language:English
Published: SAGE Publishing 2021-05-01
Series:Technology in Cancer Research & Treatment
Online Access:https://doi.org/10.1177/15330338211004954
_version_ 1811238632102559744
author Kaichun Li MD
Liying Pang MS
Xiaorong Pan MS
Shaonan Fan MS
Xinxin Wang MS
Qiaoyun Wang MS
Ping Dai MS
Wei Gao MD
Jie Gao PhD
author_facet Kaichun Li MD
Liying Pang MS
Xiaorong Pan MS
Shaonan Fan MS
Xinxin Wang MS
Qiaoyun Wang MS
Ping Dai MS
Wei Gao MD
Jie Gao PhD
author_sort Kaichun Li MD
collection DOAJ
description Salinomycin (Sal) is a potent inhibitor with effective anti-breast cancer properties in clinical therapy. The occurrence of various side effect of Sal greatly limits its application. The epidermal growth factor receptor (EGFR) family is a family of receptors highly expressed in most breast cancer cells. GE11 is a dodecapeptide which shows excellent EGFR affinity. A series of nanoparticles derivatives with GE11 peptide conjugated PLGA/TPGS were synthesized. Nanoprecipitation method was used to prepare the Sal loaded nanoparticles at the optimized concentration. The characterization, targeting efficacy, and antitumor activity were detected both in vitro and in vivo . Encapsulation of Sal in GE11 modified PLGA/TPGS nanoparticles shows an improved therapy efficacy and lower systemic side effect. This represents the delivery system a promising strategy to enhance the therapeutic effect against EGFR highly expressed breast cancer.
first_indexed 2024-04-12T12:45:05Z
format Article
id doaj.art-69d5b8c691f946398c1c5ea6f93cff8e
institution Directory Open Access Journal
issn 1533-0338
language English
last_indexed 2024-04-12T12:45:05Z
publishDate 2021-05-01
publisher SAGE Publishing
record_format Article
series Technology in Cancer Research & Treatment
spelling doaj.art-69d5b8c691f946398c1c5ea6f93cff8e2022-12-22T03:32:38ZengSAGE PublishingTechnology in Cancer Research & Treatment1533-03382021-05-012010.1177/15330338211004954GE11 Modified PLGA/TPGS Nanoparticles Targeting Delivery of Salinomycin to Breast Cancer CellsKaichun Li MD0Liying Pang MS1Xiaorong Pan MS2Shaonan Fan MS3Xinxin Wang MS4Qiaoyun Wang MS5Ping Dai MS6Wei Gao MD7Jie Gao PhD8 Department of Oncology, Shanghai Fourth People’s Hospital Affiliated to Tongji University, Shanghai, China Institute of Translational Medicine, Shanghai University, Shanghai, China Department of Oncology, Shanghai Fourth People’s Hospital Affiliated to Tongji University, Shanghai, China Department of Radiation Oncology, Shanghai Fourth People’s Hospital Affiliated to Tongji University, Shanghai, China Department of Oncology, Shanghai Fourth People’s Hospital Affiliated to Tongji University, Shanghai, China Department of Oncology, Shanghai Fourth People’s Hospital Affiliated to Tongji University, Shanghai, China Department of Oncology, Shanghai Fourth People’s Hospital Affiliated to Tongji University, Shanghai, China Department of Radiation Oncology, Shanghai Fourth People’s Hospital Affiliated to Tongji University, Shanghai, China Institute of Translational Medicine, Shanghai University, Shanghai, ChinaSalinomycin (Sal) is a potent inhibitor with effective anti-breast cancer properties in clinical therapy. The occurrence of various side effect of Sal greatly limits its application. The epidermal growth factor receptor (EGFR) family is a family of receptors highly expressed in most breast cancer cells. GE11 is a dodecapeptide which shows excellent EGFR affinity. A series of nanoparticles derivatives with GE11 peptide conjugated PLGA/TPGS were synthesized. Nanoprecipitation method was used to prepare the Sal loaded nanoparticles at the optimized concentration. The characterization, targeting efficacy, and antitumor activity were detected both in vitro and in vivo . Encapsulation of Sal in GE11 modified PLGA/TPGS nanoparticles shows an improved therapy efficacy and lower systemic side effect. This represents the delivery system a promising strategy to enhance the therapeutic effect against EGFR highly expressed breast cancer.https://doi.org/10.1177/15330338211004954
spellingShingle Kaichun Li MD
Liying Pang MS
Xiaorong Pan MS
Shaonan Fan MS
Xinxin Wang MS
Qiaoyun Wang MS
Ping Dai MS
Wei Gao MD
Jie Gao PhD
GE11 Modified PLGA/TPGS Nanoparticles Targeting Delivery of Salinomycin to Breast Cancer Cells
Technology in Cancer Research & Treatment
title GE11 Modified PLGA/TPGS Nanoparticles Targeting Delivery of Salinomycin to Breast Cancer Cells
title_full GE11 Modified PLGA/TPGS Nanoparticles Targeting Delivery of Salinomycin to Breast Cancer Cells
title_fullStr GE11 Modified PLGA/TPGS Nanoparticles Targeting Delivery of Salinomycin to Breast Cancer Cells
title_full_unstemmed GE11 Modified PLGA/TPGS Nanoparticles Targeting Delivery of Salinomycin to Breast Cancer Cells
title_short GE11 Modified PLGA/TPGS Nanoparticles Targeting Delivery of Salinomycin to Breast Cancer Cells
title_sort ge11 modified plga tpgs nanoparticles targeting delivery of salinomycin to breast cancer cells
url https://doi.org/10.1177/15330338211004954
work_keys_str_mv AT kaichunlimd ge11modifiedplgatpgsnanoparticlestargetingdeliveryofsalinomycintobreastcancercells
AT liyingpangms ge11modifiedplgatpgsnanoparticlestargetingdeliveryofsalinomycintobreastcancercells
AT xiaorongpanms ge11modifiedplgatpgsnanoparticlestargetingdeliveryofsalinomycintobreastcancercells
AT shaonanfanms ge11modifiedplgatpgsnanoparticlestargetingdeliveryofsalinomycintobreastcancercells
AT xinxinwangms ge11modifiedplgatpgsnanoparticlestargetingdeliveryofsalinomycintobreastcancercells
AT qiaoyunwangms ge11modifiedplgatpgsnanoparticlestargetingdeliveryofsalinomycintobreastcancercells
AT pingdaims ge11modifiedplgatpgsnanoparticlestargetingdeliveryofsalinomycintobreastcancercells
AT weigaomd ge11modifiedplgatpgsnanoparticlestargetingdeliveryofsalinomycintobreastcancercells
AT jiegaophd ge11modifiedplgatpgsnanoparticlestargetingdeliveryofsalinomycintobreastcancercells